Zhu J - Search Results

1

Hologram quantitative structure activity relationship, docking, and molecular dynamics studies of inhibitors for CXCR4.

Zhang C, Du C, Feng Z, Zhu J, Li Y. Zhang C, et al. Among authors: zhu j. Chem Biol Drug Des. 2015 Feb;85(2):119-36. doi: 10.1111/cbdd.12377. Epub 2014 Jul 10. Chem Biol Drug Des. 2015. PMID: 24923360

2

Recent developments of in silico predictions of oral bioavailability.

Zhu J, Wang J, Yu H, Li Y, Hou T. Zhu J, et al. Comb Chem High Throughput Screen. 2011 Jun 1;14(5):362-74. doi: 10.2174/138620711795508368. Comb Chem High Throughput Screen. 2011. PMID: 21470180 Review.

3

Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses.

Zhu J, Li Y, Yu H, Zhang L, Mao X, Hou T. Zhu J, et al. Comb Chem High Throughput Screen. 2012 Jul;15(6):439-50. doi: 10.2174/138620712800563918. Comb Chem High Throughput Screen. 2012. PMID: 22263860

4

Theoretical studies on beta and delta isoform-specific binding mechanisms of phosphoinositide 3-kinase inhibitors.

Zhu J, Pan P, Li Y, Wang M, Li D, Cao B, Mao X, Hou T. Zhu J, et al. Mol Biosyst. 2014 Mar 4;10(3):454-66. doi: 10.1039/c3mb70314b. Epub 2013 Dec 16. Mol Biosyst. 2014. PMID: 24336903

5

Theoretical studies on the selective mechanisms of GSK3β and CDK2 by molecular dynamics simulations and free energy calculations.

Zhao S, Zhu J, Xu L, Jin J. Zhao S, et al. Among authors: zhu j. Chem Biol Drug Des. 2017 Jun;89(6):846-855. doi: 10.1111/cbdd.12907. Epub 2016 Dec 7. Chem Biol Drug Des. 2017. PMID: 27863047

6

Insight into the selective mechanism of phosphoinositide 3-kinase γ with benzothiazole and thiazolopiperidine γ-specific inhibitors by in silico approaches.

Zhu J, Li K, Xu L, Jin J. Zhu J, et al. Chem Biol Drug Des. 2019 May;93(5):818-831. doi: 10.1111/cbdd.13469. Epub 2019 Jan 11. Chem Biol Drug Des. 2019. PMID: 30582283

7

Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.

Zhu J, Wu Y, Xu L, Jin J. Zhu J, et al. Curr Comput Aided Drug Des. 2020;16(1):17-30. doi: 10.2174/1573409915666190708102459. Curr Comput Aided Drug Des. 2020. PMID: 31284868 Free PMC article.

8

Integrated molecular modeling techniques to reveal selective mechanisms of inhibitors to PI3Kδ with marketed Idelalisib.

Zhu J, Jia L, Jiang Y, Yu Q, Xu L, Cai Y, Chen Y, Li H, Gang H, Liang W, Jin J. Zhu J, et al. Chem Biol Drug Des. 2021 Jun;97(6):1158-1169. doi: 10.1111/cbdd.13838. Epub 2021 Mar 13. Chem Biol Drug Des. 2021. PMID: 33657663

9

Theoretical study of myriocin-binding mechanism targeting serine palmitoyltransferase.

Yu L, Jiang Y, Xu L, Jin J, Pei Z, Zhu J. Yu L, et al. Among authors: zhu j. Chem Biol Drug Des. 2022 Mar;99(3):373-381. doi: 10.1111/cbdd.13991. Epub 2021 Dec 10. Chem Biol Drug Des. 2022. PMID: 34862732

10

Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignancies.

Zhu J, Hou T, Mao X. Zhu J, et al. Drug Discov Today. 2015 Aug;20(8):988-94. doi: 10.1016/j.drudis.2015.03.009. Epub 2015 Apr 6. Drug Discov Today. 2015. PMID: 25857437 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,088 results

Search Page

Filters